INBICON A/S: Financial statements 2020
CVR: 27036635
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
INBICON A/S (CVR 27036635) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 25,651,000 and a net result of DKK 21,322,000 compared with DKK 3,481,000 the year before. That is an increase of 456.3% compared with the year before. Equity in the 2020 report amounted to DKK 33,612,000. The solvency ratio was 99.2%.
- Revenue
- DKK 0
- Gross Profit
- DKK 25,651,000
- Profit/Loss
- DKK 21,322,000
- Equity
- DKK 33,612,000
- Total Assets
- DKK 33,866,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 25.7 mio. | 21.3 mio. | 33.6 mio. | - |
| 2019 | - | 4.6 mio. | 3.5 mio. | 12.3 mio. | - |
| 2018 | - | -16.3 mio. | -12.7 mio. | 8.8 mio. | - |
| 2017 | - | -4.4 mio. | -7.6 mio. | 21.5 mio. | - |
| 2016 | - | -13.8 mio. | -16.8 mio. | 47.1 mio. | - |
Official annual report
How creditworthy is INBICON A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
INBICON A/S has published its annual report for 2019. Gross profit came to DKK 4,611,000, and the net result was DKK 3,481,000.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.